-
Gilead gets USFDA approval for Veklury (remdesivir) to treat COVID-19
expresspharma
October 26, 2020
Gilead Sciences announced that the US Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalisation.
-
USFDA approves IND application from Reven Pharma for Rejuveinix to treat COVID-19
expresspharma
October 26, 2020
RJX is an IV formulation being developed for treatment of inflammatory disorders, including COVID-19 patients with viral sepsis, multi-system inflammation, cytokine release syndrome, shock, ARDS and multi-organ failure.
-
Second wave of COVID-19 vaccines may not be needed to reach higher efficacy bar than first batch
expresspharma
October 26, 2020
It would be best for second wave vaccines to underscore ideal subpopulations or manufacturing and storage advantages that could underscore uptake.
-
Mexico may not follow FDA and approve remdesivir for COVID-19
expresspharma
October 26, 2020
WHO Solidarity drug trial last week concluded remdesivir has little or no impact on a patient’s chances of surviving COVID-19.
-
FDA approves first treatment for COVID-19
worldpharmanews
October 23, 2020
The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitali
-
Granules India gets US FDA approval for potassium chloride ER tablets
expresspharma
October 23, 2020
Granules announced that it has received marketing approval from the US FDA for Potassium Chloride Extended Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg) for the treatment of patients with hypokalemia.
-
Aurobindo Pharma receives USFDA approval for Acetaminophen Injection
expresspharma
October 23, 2020
It is indicated for the treatment of mild to moderate pain in adult and paediatric patients two years and older.
-
VENCLEXTA Receives FDA Approval for AML
americanpharmaceuticalreview
October 22, 2020
AbbVie announced the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly-diagnosed acute myeloid leukemia ..
-
Zydus Cadila gets final US FDA nod for Solifenacin Succinate Tablets
expresspharma
October 22, 2020
There are used as a symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in patients with overactive bladder syndrome.
-
Strides receives USFDA approval for Ethacrynic Acid Tablets
expresspharma
October 22, 2020
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food & Drug Administration (USFDA).